Granules India has informed that the Board of Directors appointed Rajiv Pritidas Kakodkar (DIN: 01519590), as an Additional Director, categorized as Non-Executive Independent, on the Board of the Company with effect from February 20, 2024 and his appointment is subject to the approval of the members. The Board has approved this appointment by passing a resolution through the circulation. Pursuant to NSE Circular no. NSE/CML/2018/24 dated June 20, 2018, it has confirmed that Rajiv Pritidas Kakodkar is not debarred from holding the office of Director by virtue of any order of SEBI or any other authority. He meets the criteria for being appointed as an Independent Director under the statutes applicable to the Company. The details required under Regulation 30 of the SEBI Listing Regulations, read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, with respect to the above appointment, is given in the Annexure enclosed.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |